Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01213641 · ClinicalTrials.gov registry record
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 288
- Enrollment target
NCT01213641 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 288 participants.
The verdict
NCT01213641 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2009-11 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01213641
The ClinicalTrials.gov registry entry for NCT01213641 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01213641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01213641 about?
NCT01213641 is a clinical study titled "Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients". The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.
What is the current status of trial NCT01213641?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2009-11. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01213641?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.